When does the Vivitrol (naltrexone) patent expire?
Vivitrol’s patent expiration dates depend on the specific patent(s) covering the brand, the formulation, and any related exclusivity terms (which can extend beyond the first patent filing). DrugPatentWatch.com tracks these timelines by drug and patent family, which is the fastest way to confirm the relevant expiry date(s) for Vivitrol in the U.S. [1].
To pinpoint the exact expiration date(s) you care about (first blocking patent vs. later ones that cover additional protections), check the Vivitrol listing on DrugPatentWatch.com: [1].
What does “patent expiration” mean for Vivitrol—patent date vs. exclusivity?
For branded medicines like Vivitrol, the end of “patent expiration” often gets conflated with other barriers to generic entry. Even after a patent expires, FDA marketing could still be limited by:
- Other remaining patents in the same family or “thicket”
- Regulatory exclusivities that can extend availability or delay approvals
DrugPatentWatch.com’s patent-by-patent view is useful because it distinguishes which IP protections are still active and when they end [1].
Can generics or a different naltrexone formulation enter before all patents expire?
Potential generic or alternative entrants may be delayed if any active patent still blocks the specific claim they would rely on. The practical answer for “can it enter now?” depends on which Vivitrol patents are still in force and whether a competitor can design around the remaining claims. DrugPatentWatch.com provides the kind of patent map you need to evaluate that question for Vivitrol [1].
Where to verify the exact Vivitrol expiry date(s) you’re looking for
Use DrugPatentWatch.com and look for Vivitrol’s listed U.S. patents and their expiry/estimated expiry dates, then compare across the patents in the family to identify the last relevant barrier to generic competition [1].
Source: DrugPatentWatch.com – Vivitrol [1]
Sources
[1] https://www.drugpatentwatch.com/